{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Gu L"],"funding":["HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","NIDDK NIH HHS","NIGMS NIH HHS"],"pagination":["e2320934121"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11046679"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["121(17)"],"pubmed_abstract":["Cullin RING E3 ligases (CRL) have emerged as key regulators of disease-modifying pathways and therapeutic targets. Cullin3 (Cul3)-containing CRL (CRL3) has been implicated in regulating hepatic insulin and oxidative stress signaling. However, CRL3 function in liver pathophysiology is poorly defined. Here, we report that hepatocyte Cul3 knockout results in rapid resolution of steatosis in obese mice. However, the remarkable resistance of hepatocyte Cul3 knockout mice to developing steatosis does not lead to overall metabolic improvement but causes systemic metabolic disturbances. Liver transcriptomics analysis identifies that CRL3 inactivation causes persistent activation of the nuclear factor erythroid 2-related factor 2 (NRF2) antioxidant defense pathway, which also reprograms the lipid t"],"journal":["Proceedings of the National Academy of Sciences of the United States of America"],"pubmed_title":["Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress, hepatic lipodystrophy, and systemic insulin resistance."],"pmcid":["PMC11046679"],"funding_grant_id":["P30 DK020593","P20 GM103447","R01 DK134316","1R01DK117965","1R01DK134316","R01 DK117965","U24 DK059637","R01 DK131064","5R01DK131064"],"pubmed_authors":["Friedman JE","Chen J","Clayton YD","Li T","Gu L","Du Y","Matye DJ","Hasan MN"],"additional_accession":[]},"is_claimable":false,"name":"Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress, hepatic lipodystrophy, and systemic insulin resistance.","description":"Cullin RING E3 ligases (CRL) have emerged as key regulators of disease-modifying pathways and therapeutic targets. Cullin3 (Cul3)-containing CRL (CRL3) has been implicated in regulating hepatic insulin and oxidative stress signaling. However, CRL3 function in liver pathophysiology is poorly defined. Here, we report that hepatocyte Cul3 knockout results in rapid resolution of steatosis in obese mice. However, the remarkable resistance of hepatocyte Cul3 knockout mice to developing steatosis does not lead to overall metabolic improvement but causes systemic metabolic disturbances. Liver transcriptomics analysis identifies that CRL3 inactivation causes persistent activation of the nuclear factor erythroid 2-related factor 2 (NRF2) antioxidant defense pathway, which also reprograms the lipid t","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Apr","modification":"2025-04-22T21:08:35.432Z","creation":"2025-04-06T03:26:45.316Z"},"accession":"S-EPMC11046679","cross_references":{"pubmed":["38630726"],"doi":["10.1073/pnas.2320934121"]}}